PERCEPTIVE ADVISORS LLC's Net Worth

$745 Million

Estimate Recalculated Feb 21, 2024 05:01PM EST

Who is PERCEPTIVE ADVISORS LLC?

PERCEPTIVE ADVISORS LLC has an estimated net worth of $745 Million. This is based on reported shares across multiple companies, which include CARGO Therapeutics, Inc., VBI VACCINES INC., ZOGENIX, INC., Prometheus Biosciences, Inc., BIOSANTE PHARMACEUTICALS INC, Crinetics Pharmaceuticals, Inc., ALBIREO PHARMA, INC., Nautilus Biotechnology, Inc., Aldeyra Therapeutics, Inc., ANTARES PHARMA INC, Athira Pharma, Inc., Verrica Pharmaceuticals Inc., LianBio, MeiraGTx Holdings plc, AP PHARMA INC /DE/, ADMA BIOLOGICS, INC., AMICUS THERAPEUTICS, INC., Global Blood Therapeutics, Inc., Cerevel Therapeutics Holdings, Inc., Kadmon Holdings, Inc., Menlo Therapeutics Inc., AGILE THERAPEUTICS INC, Solid Biosciences Inc., IsoPlexis Corp, XTL BIOPHARMACEUTICALS LTD, Lyra Therapeutics, Inc., Landos Biopharma, Inc., Motus GI Holdings, Inc., VBI Vaccines Inc/BC, Corium International, Inc., Astria Therapeutics, Inc., SCYNEXIS INC, LEAP THERAPEUTICS, INC., Rain Therapeutics Inc., Quotient Ltd, Athenex, Inc., LA JOLLA PHARMACEUTICAL CO, Versartis, Inc., ACELRX PHARMACEUTICALS INC, Dova Pharmaceuticals Inc., CHEMBIO DIAGNOSTICS, INC., SOLENO THERAPEUTICS INC, REPROS THERAPEUTICS INC., SYNAGEVA BIOPHARMA CORP, Acrivon Therapeutics, Inc., OPTIMER PHARMACEUTICALS INC, Aegerion Pharmaceuticals, Inc., Foamix Pharmaceuticals Ltd., MIRAVANT MEDICAL TECHNOLOGIES, INDEVUS PHARMACEUTICALS INC, BIOENVISION INC, MACROCHEM CORP, PENWEST PHARMACEUTICALS CO, and CYPRESS BIOSCIENCE INC.

SEC CIK

PERCEPTIVE ADVISORS LLC's CIK is 0001224962

Past Insider Trading and Trends

2008 was PERCEPTIVE ADVISORS LLC's most active year for acquiring shares with 204 total transactions. PERCEPTIVE ADVISORS LLC's most active month to acquire stocks was the month of December. 2021 was PERCEPTIVE ADVISORS LLC's most active year for disposing of shares, totalling 47 transactions. PERCEPTIVE ADVISORS LLC's most active month to dispose stocks was the month of December. 2022 saw PERCEPTIVE ADVISORS LLC paying a total of $222,247,925.28 for 18,920,433 shares, this is the most they've acquired in one year. In 2010 PERCEPTIVE ADVISORS LLC cashed out on 6,476,446 shares for a total of $32,382,230.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

CARGO Therapeutics, Inc. (CRGX) Snapshot price: $23

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
3.25M
$15.00
$4,999,995.00
3.25M
Nov 14
Form 3
0
0
No matching records found

VBI VACCINES INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
+118.25%
3.38M
$3.05
$10,321,062.75
6.25M
Dec 6
Form 4
+119.60%
3.38M
$3.05
$10,321,062.75
6.21M
Dec 6
Form 4
+24.90%
650K
$2.08
$1,352,000.00
3.26M
Aug 14
Form 3/A
0
0
No matching records found

ZOGENIX, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+2.52%
100K
$52.00
$5,200,000.00
4.07M
Aug 10
Form 4
+8.17%
300K
$37.50
$11,250,000.00
3.97M
Oct 3
Form 4
+6.44%
222.06K
$32.83
$7,290,059.36
3.67M
Sep 29
Form 4
+5.37%
175.65K
$14.45
$2,538,185.85
3.45M
Jun 30
Form 3
0
0
No matching records found

Prometheus Biosciences, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
3.31M
$19.00
3.31M
Mar 16
Form 3
0
0
No matching records found

BIOSANTE PHARMACEUTICALS INC (ANIP) Snapshot price: $56.1

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-89.56%
-1.79M
$4.27
-$8,348,265.00
209.1K
Dec 2 - Dec 3
Form 4
+0.80%
15.9K
$9.87
$156,856.68
2M
Oct 8
Form 4
+1.02%
20K
$10.00
$200,084.00
1.99M
Oct 6 - Oct 7
Form 4
+1.65%
32K
$9.82
$314,196.65
1.97M
Oct 4 - Oct 5
Form 4
+1.66%
31.5K
$9.39
$295,830.00
1.93M
Sep 30 - Oct 1
Form 4
+1.30%
24.5K
$7.69
$188,287.40
1.9M
Sep 14
Form 4
+1.40%
25.9K
$7.17
$185,653.79
1.88M
Sep 13
Form 4
+0.25%
4.7K
$6.85
$32,195.00
1.85M
Sep 9
Form 4
+1.04%
19K
$6.84
$129,936.70
1.85M
Aug 30 - Aug 31
Form 4
+2.92%
51.9K
$5.83
$302,466.24
1.83M
Aug 18 - Aug 19
Form 4
0
$5.30
-$80.00
7.25K
Aug 16
Form 4
+0.14%
2.5K
$4.75
$11,875.00
1.77M
Aug 12
Form 4
+1.35%
23.6K
$4.72
$111,333.00
1.77M
Aug 11
Form 4
+1.65%
28.45K
$5.67
$161,456.56
1.75M
Jul 19
Form 4
+1.27%
21.55K
$5.91
$127,434.18
1.72M
Jul 15 - Jul 16
Form 4/A
+61.90%
650K
$6.00
$3,900,000.00
1.7M
May 14
Form 4
+61.90%
650K
$6.00
$3,900,000.00
1.7M
May 11
Form 4
-7.68%
-87.40K
$6.44
-$562,576.32
1.05M
Feb 3
Form 4
-18.31%
-255.00K
$5.67
-$1,446,550.00
1.14M
Jan 21 - Jan 23
Form 3
0
0
No matching records found